Drugs / Seasonal Quadrivalent influenza vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT03160118 | Mar → May 2017 | — | University Hospital, Ghent | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03650114 Background | Dec 2018 → Sep 2028 expected | multiple sclerosis | Novartis Pharmaceuticals | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Seasonal Quadrivalent influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03650114 ↗ |
| Modality | Vaccine | “quadrivalent, inactivated, split influenza virus vaccine” NCT03160118 ↗ |